Femta Pharmaceuticals femtapharma.com


Public lists: Pharma Startups (4743)

Femta is developing a new generation of antibody therapeutics for major disease indications.

Femta is developing a new generation of antibody therapeutics for major disease indications.

Company (Alive / Active)

Phone: 858-622-0424

Fax: 858-622-0424

4510 Executive Drive
Suite 322
San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Femta Pharmaceuticals $3.2M Jul 20, 2010
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Femta Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Competitors

Company Status Description Investors

Nuon Therapeutics

San Mateo, California, United States
Alive / ActiveNuon Therapeutics discovers novel uses for marketed drugs. The advantage of this approach is that the development program for the marketed indication will have investigated the compounds toxicity and established its tolerability. This makes it possible to proceed directly to clinical trials once the efficacy of the compound has been established in animal models. The costs and risks involved in the drug development process are greatly reduced. Tranilast is under development for the treatment of p...Show allLogin to see details

Recodgen

Alive / ActiveRecodgen is developing therapeutics targeting genetic expressions to diseaseLogin to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Humanized anti-il-6 antibodies Sep 23, 2011 May 08, 2012 Patent
Humanized anti-il-6 antibodies Nov 13, 2009 Nov 22, 2011 Patent